As of April 29, 2025, NRx Pharmaceuticals (NRXP) has a market cap of $34.762 million USD. According to our data, NRx Pharmaceuticals is ranked No.8311 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $34.76 M |
-6.59%
|
Dec 31, 2024 | $37.21 M |
-52.17%
|
Dec 29, 2023 | $77.81 M |
-58.56%
|
Dec 30, 2022 | $0.19 B |
-76.78%
|
Dec 31, 2021 | $0.81 B |
-80.41%
|
Dec 31, 2020 | $4.13 B |
130.19%
|
Dec 31, 2019 | $1.79 B |
3.92%
|
Dec 31, 2018 | $1.73 B |
5.37%
|
Dec 29, 2017 | $1.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amarin Corporation
AMRN
|
$0.21 B |
0.000 M
|
![]() Ireland
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.77 B |
0.000 M
|
![]() USA
|
![]() Catalyst Pharmaceuticals
CPRX
|
$2.96 B |
-0.000 M
|
![]() USA
|
![]() Corcept Therapeutics
CORT
|
$7.77 B |
-0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Jazz Pharmaceuticals
JAZZ
|
$7.17 B |
-0.000 M
|
![]() Ireland
|
![]() Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
![]() USA
|
![]() Omeros Corporation
OMER
|
$0.42 B |
0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.91 B |
0.000 M
|
![]() USA
|
![]() Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.81 B |
0.000 M
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.26 B |
0.000 M
|
![]() USA
|
Market Cap | = | NRXP Stock Price | * | NRXP Shares Outstanding |
= | $2.06 | * | 16.92 M | |
= | $34.76 M |